Category: Stryker Corp.Syndicate content

Michigan judge shoots down settlement alleged by Biomet in poaching spat with Stryker | Medtech legal news for the week of July 28, 2014

July 28, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Judge nixes alleged settlement in Stryker, Biomet poaching spat; Boston Scientific loses bids to exclude testimony in pelvic mesh trials; Occlutech claims another win over St. Jude Medical; Align Tech declares a 'total win' as federal circuit reverses ITC ruling; Report: Medtronic shareholder sues to block Covidien merger

Judge nixes alleged settlement in Stryker, Biomet poaching spat

July 23, 2014 by Brad Perriello

Ex-Stryker CFO Hartman takes over at ConMed

July 23, 2014 by Arezu Sarvestani

ConMed names former Stryker CFO Curt Hartman interim CEO and lowers its outlook for the rest of the year.

Former Styker CFO takes over at ConMED

Surgical device maker ConMed (NSDQ:CNMD) took a major hit on Wall Street today after announcing some turnover at the top and lowering its financial outlook for the rest of the year.

Judge nixes alleged settlement in Stryker, Biomet poaching spat

July 23, 2014 by Brad Perriello

A Michigan federal judge denies a settlement in the poaching spat between Biomet and Stryker and a pair of ex-Stryker sales reps.

Judge nixes alleged settlement in Stryker, Biomet poaching spat

Covidien promotes Hanson to group president role | Personnel Moves

July 22, 2014 by Brad Perriello

Covidien names Bryan Hanson group president, with oversight of all of the medical device company's businesses.

Covidien promotes Hanson to group president role | Personnel Moves

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Stryker's Q2 earnings meet The Street

July 17, 2014 by Brad Perriello

Stryker Corp. reports 2nd-quarter earnings that meet Wall Street's expectations, despite flat profit growth on 7% sales growth.

Stryker's Q2 earnings meet The Street

Stryker (NYSE:SYK) said today that its 2nd-quarter earnings met expectations on Wall Street, despite flat profit growth, on 7% sales growth.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Stryker to deal bone growth protein assets to Mariel Therapeutics

July 9, 2014 by Brad Perriello

Stryker Corp. agrees to sell its bone morphogenetic protein-7 assets to Mariel Therapeutics, which plans to investigate BMP-7 as a possible treatment for a variety of conditions.

Stryker to deal bone growth protein assets to Mariel Therapeutics

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Appeals court overturns Stryker win in Hill-Rom patent spat

June 30, 2014 by Brad Perriello

A federal appeals court overturns Stryker's win over Hill-Rom in a patent spat over hospital bed monitoring systems.

Appeals court overturns Stryker win in Hill-Rom patent spat

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp